Peptide-based PET tracer targeting LAG-3 for evaluating the efficacy of immunotherapy in melanoma
Background
Lymphocyte activation gene 3 (LAG-3) is expressed on activated immune cells and has emerged as a promising target for immune checkpoints blockade. However, conflicting findings have been reported regarding the association between LAG-3 expr…